Malignant mesothelioma: A clinical study of 238 cases

Industrial Health

Volumn 49, Issue 2, 2011, Pages 166-172

  Haber, Steven E ^a   Haber, Jason M ^b  

^a Texas Occupational Medicine Institute   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Asbestos; Diagnosis; Exposure; Latency; Mesothelioma; Peritoneal cancer; Pleural cancer

Indexed keywords

ADULT; AGED; ARTICLE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; MALE; MESOTHELIOMA; MIDDLE AGED; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; PERITONEUM TUMOR; RESPIRATORY TRACT TUMOR; SEX RATIO; SMOKING; TIME; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PERITONEAL NEOPLASMS; RESPIRATORY TRACT NEOPLASMS; SEX DISTRIBUTION; SMOKING; TIME FACTORS; UNITED STATES;

EID: 79955493160     PISSN: 00198366     EISSN: None     Source Type: Journal    
DOI: 10.2486/indhealth.MS1147     Document Type: Article

References (43)

1. Roggli VL, Sharma A, Butnor KK, Sporn T, Vollmer RT (2002) Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases. Ultrastruct Pathol 26, 55-65.
2. Jones MA, Young RH, Scully RE (1995) Malignant mesothelioma of the tunica vaginalis. A clinicopathologic analysis of 11 cases with review of the literature. Am J Surg Pathol 19, 815-25.
3. Roggli VL (1981) Pericardial mesothelioma after exposure to asbestos. N Eng J Med 304, 1045.
4. Hassan R, Alexander R (2005) Nonpleural mesotheliomas: mesothelioma of the peritoneum, tunica vaginalis, and pericardium. Hematol Oncol Clin North Am 19, 1067-1087.
5. Price B (1997) Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol 145, 211-218.
6. Connelly RR, Spirtas R, Myers MH, Percy CL, Fraumeni JF Jr. (1987) Demographic patterns for mesothelioma in the United States. J Natl Cancer Inst 78, 1053-1060.
7. Price B, Ware A (2004) Mesothelioma trends in the United States: an update based on surveillance, epidemiology, and end results program data for 1973 through 2003. Am J Epidemiol 159, 107-112.
8. Lemen RA (2006) Epidemiology of asbestos-related diseases and the knowledge that led to what is known today. In: Asbestos: Risk assessment, epidemiology, and health effects, Dodson RF and Hammar SP (Eds.), 201-308, CRC Press, Boca Raton.
9. Nicholson WJ, Perkel G, Selikoff IJ (1982) Occupational exposure to asbestos: population at risk and projected mortality- 1980-2030. Am J Ind Med 3, 259-311.
10. Bianchi C, Brollo A, Ramani L, Bianchi T, Giarelli L (2001) Asbestos exposure in malignant mesothelioma of the pleura: a survey of 557 cases. Ind Health 39, 161-167.
11. Yates DH, Corrin B, Stidolph PN, Browne K (1997) Malignant mesothelioma in south east England: clinicopathological experience of 272 cases. Thorax 52, 507-512.
12. Pisick E, Salgia R (2005) Molecular biology of malignant mesothelioma: a review. Hematol Oncol Clin North Am 19, 997-1023.
13. Agudo A, González CA, Bleda MJ, Ramírez J, Hernández S, López F, Calleja A, Panadès R, Turuguet D, Escolar A, Beltrán M, González-Moya JE (2000) Occupation and risk of malignant pleural mesothelioma: a case-control study in Spain. Am J Ind Med 37, 159-168.
14. Hemminki K, Li X (2003) Time trends and occupational risk factors for pleural mesothelioma in Sweden. J Occup Environ Med 45, 456-61.
15. National Occupational Health and Safety Commission (2 0 0 0, 2 0 0 1, 2 0 0 2, 2 0 0 3, 2 0 0 4) Au s t r a l i a Mesothelioma Register. The incidence of mesothelioma in Australia; Australian mesothelioma register report, Canberra, ACT.
16. Rödelsperger K, Jöckel K-H, Pohlabeln H, Römer W, Woitowitz H-J (2001) Asbestos and man-made vitreous fibers as risk factors for diffuse malignant mesothelioma: results from a German hospital-based casecontrol study. Am J Ind Med 39, 262-275.
17. Roggli VL, Sharma A (2004) Analysis of tissue mineral fiber content. In: Pathology of asbestos-associated diseases, 2nd Ed., Roggli VL, Oury TD and Sporn TA, (Eds.), 309-354, Little Brown, Boston.
18. Ruffie P, Lehmann M, Galateau-Salle F, Lagrange JL, Pairon JC (2001) Malignant mesothelioma. Br J Cancer 84, S49-50.
19. Rusch WW (1995) Clinical features and current treatment of diffuse malignant pleural mesothelioma. Lung Cancer 12, S127-46.
20. Hillerdal G (1995) Pleural malignancies including mesothelioma. Curr Open Pulm Med 1, 339-343.
21. Borasio P, Berruti A, Billé A, Giaj Levra M, Giardino R, Ardisonne F (2008) Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients. Eur J Cardiothorac Surg 33, 307-313.
22. Sovak MA, Aisner SC, Aisner J (2008) Tumors of the pleura and mediastinum. In: Abeloff's Clinical Oncology, 4th Ed., Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB and McKenna WG (Eds.), 1367-1390, Churchill Livingstone, Philadelphia.
23. Chailleux E, Dabouis G, Pioche D, de Lajartre M, de Lajartre A, Rembeaux A, Germaud P (1988) Prognostic factors in diffuse malignant pleural mesothelioma. Chest 93, 159-162.
24. Antman KH, Blum RH, Greenberger JS, Flowerdew G, Skarin AT, Canellos GP (1980) Multimodality therapy for malignant mesothelioma based on a study of natural history. Am J Med 68, 356-362.
25. McDonald AD, McDonald JC (1980) Malignant mesothelioma in North America. Cancer 46, 1650-6.
26. Selikoff IJ, Hammond EC, Seidman H (1979) Mortality experience of insulation workers in the United States and Canada, 1943-1976. Ann NY Acad Sci 330, 91-116.
27. Selikoff IJ, Hammond EC, Seidman H (1980) Latency of asbestos disease among insulation workers in the United States and Canada. Cancer 46, 2736-2740.
28. Lanphear BP, Bucher CR (1992) Latent period for malignant mesothelioma of occupational origin. J Occup Med 34, 718-721.
29. Whitwell F, Rawcliffe RM (1971) Diffuse malignant pleural mesothelioma and asbestos exposure. Thorax 26, 6-22.
30. Bianchi C, Giarelli L, Grandi G, Brollo A, Ramani L, Zuch C (1997) Latency periods in asbestos-related mesothelioma of the pleura. Eur J Cancer Prev 6, 162-6.
31. Neuman V, Günther S, Müller KM, Fisher M (2001) Malignant mesothelioma- German mesothelioma register 1987-1999. Int Arch Occup Environ Health 74, 383-395.
32. Edwards JG, Abrams KR, Leverment JN, Spyt TJ, Waller DA, O'Byrne KJ (2000) Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems. Thorax 55, 731-735.
33. Flores RM, Zakowski M, Venkatraman E, Krug L, Rosenzweig K, Dycoco J, Lee C, Yeoh C, Bains M, Rusch V (2007) Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center. J Thorax Oncol 2, 957-965.
34. Scagliotti GV, Novello S (2005) State of the art in mesothelioma. Annals Oncol 16(S), H240-5.
35. Berry G, deKlerk NH, Reid A, Ambrosini G, Fritschi L, Olsen N, Merler E, Musk A (2004) Malignant pleural and peritoneal mesotheliomas in former miners and millers of crocidolite at Wittenoom, Western Australia. Occup Environ Med 61, e14-6.
36. Sterman DH, Kaiser LR, Albelda SM (1999) Advances in the treatment of malignant pleural mesothelioma. Chest 116, 504-520.
37. Van Ruth S, Baas P, Zoetmulder FA (2003) Surgical treatment of malignant pleural mesothelioma: a review. Chest 123, 551-561.
38. Zellos LS, Sugarbaker DJ (2002) Multimodality treatment of diffuse malignant pleural mesothelioma. Semen Oncol 29, 41-50.
39. Gorini G, De Gregorio G, Silvestri S, Chellini E, Cupelli V, Seniori Constantini A (2005) Survival of malignant pleural mesothelioma cases in the Tuscan Mesothelioma Register, 1988-2000: a population-based study. Eur J Cancer Prev 14, 195-199.
40. Pistolesi M, Rusthoven J (2004) Malignant pleural mesothelioma. Chest 126, 1318-1329.
41. Loggie BW, Fleming RA, McQuellan RP, Russell GB, Geisinger KR, Levine EA (2001) Prospective trial for the treatment of malignant peritoneal mesothelioma. Am Surg 67, 999-1003.
42. Sugarbaker PH, Welch LS, Mohamed F, Glehen O (2003) A review of peritoneal mesothelioma at the Washington Center Institute. Surg Oncol Clin N Amer 12, 605-621.
43. Feldman AL, Libutti SK, Pingpank JF, Bartlett DL, Beresnev TH, Mavroukakis SM, Steinberg SM, Liewehr DJ, Kleiner DE, Alexander HR (2003) Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol 21, 4560-4567.